[The phosphate and methemoglobin content of the erythrocytes in patients with ischemic heart disease].
Cardiac insufficiency due to chronic ischemic heart disease is accompanied by a reduction of total phosphate at the expense of its organic part with a simultaneous increase of the role of inorganic phosphate during increase of methemoglobin in the erythrocytes. After traditional therapy the methemoglobin level continued to rise while inorganic phosphate and the level of 2,3-DPH decreased. Treatment including myldronate caused an increase of 2,3-DPH in erythrocytes and a decrease of methemoglobin indicating an improvement of the oxygen transport function of the blood.
Sisetskiĭ
A P
AP
Artiuk
V P
VP
Sakharchuk
I I
II
Starodub
N F
NF
D019794:2,3-Diphosphoglycerate; D002908:Chronic Disease; D003327:Coronary Disease / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D004163:Diphosphoglyceric Acids / Q000097:blood; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000737:chemistry*; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008706:Methemoglobin / Q000032:analysis*; D010710:Phosphates / Q000097:blood*
D004163:Diphosphoglyceric Acids; D010710:Phosphates; D019794:2,3-Diphosphoglycerate; D008706:Methemoglobin
Soderzhanie fosfatov i metgemoglobina v éritrotsitakh bol'nykh ishemicheskoĭ bolezn'iu sredtsa.